Related references
Note: Only part of the references are listed.Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars
Grace C. Limandjaja et al.
EXPERIMENTAL DERMATOLOGY (2021)
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
William Damsky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Basics and recent advances in the pathophysiology of atopic dermatitis
Takeshi Nakahara et al.
JOURNAL OF DERMATOLOGY (2021)
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
Julie K. Nguyen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)
Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta-analysis
L. Guo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Neuroimmune interactions in chronic itch of atopic dermatitis
G. Yosipovitch et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro
Ying Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models
Grace C. Limandjaja et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches
Emily E. Limmer et al.
DERMATOLOGY AND THERAPY (2020)
Combination therapy of refractory keloid with ultrapulse fractional carbon dioxide (CO2) laser and topical triamcinolone in Asians-long-termprevention of keloid recurrence
Jue Wang et al.
DERMATOLOGIC THERAPY (2020)
The Roles of Inflammation in Keloid and Hypertrophic Scars
Zheng-Cai Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Mechanical and Physical Regulation of Fibroblast-Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology
Mirko D'Urso et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
Krzysztof Szalus et al.
MICROORGANISMS (2020)
Fibroblast Proliferation and Migration in Wound Healing by Phytochemicals: Evidence for a Novel Synergic Outcome
Roberta Addis et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
STAT3 signalling pathway is implicated in keloid pathogenesis by preliminary transcriptome and open chromatin analyses
Yun-Shain Lee et al.
EXPERIMENTAL DERMATOLOGY (2019)
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
Michael D. Howell et al.
FRONTIERS IN IMMUNOLOGY (2019)
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Analysis of Keloid Response to 5-Fluorouracil Treatment and Long-Term Prevention of Keloid Recurrence
Ryan LaRanger et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Animal Models for Studies of Keloid Scarring
Dorothy M. Supp
ADVANCES IN WOUND CARE (2019)
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Farzan Solimani et al.
FRONTIERS IN IMMUNOLOGY (2019)
A new treatment of hypertrophic and keloid scars with combined triamcinolone and verapamil: a retrospective study
S. B. Kant et al.
EUROPEAN JOURNAL OF PLASTIC SURGERY (2018)
Surgical Excision and Adjuvant Brachytherapy vs External Beam Radiation for the Effective Treatment of Keloids: 10-Year Institutional Retrospective Analysis
Don Hoang et al.
AESTHETIC SURGERY JOURNAL (2017)
Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis
Rei Ogawa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Landon K. Oetjen et al.
CELL (2017)
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Stanley B. Cohen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Burden of Keloid Disease: A Cross-sectional Health-related Quality of Life Assessment
Eveline Bijlard et al.
ACTA DERMATO-VENEREOLOGICA (2017)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
New approach to the understanding of keloid: psychoneuroimmune- endocrine aspects
Bernardo Hochman et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2015)
MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O'Shea et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pulsed dye laser for the treatment of keloid and hypertrophic scars: a systematic review
Jacqueline Michelle G. de las Alas et al.
EXPERT REVIEW OF MEDICAL DEVICES (2012)
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gerd G. Gauglitz et al.
MOLECULAR MEDICINE (2011)
Cytokine Profiling and Stat3 Phosphorylation in Epithelial-Mesenchymal Interactions between Keloid Keratinocytes and Fibroblasts
Cheh P. Lim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Therapeutic targeting of Janus kinases
Marko Pesu et al.
IMMUNOLOGICAL REVIEWS (2008)
Nonsurgical management of hypertrophic scars: Evidence-based therapies, standard practices, and emerging methods
Bishara S. Atiyeh
AESTHETIC PLASTIC SURGERY (2007)
Mechanical stimulation increases collagen type I and collagen 1219 type III gene expression of stem cell-collagen sponge constructs for patellar tendon repair
Natalia Juncosa-Melvin et al.
TISSUE ENGINEERING (2007)
Abnormal wound heating: keloids
David T. Robles et al.
CLINICS IN DERMATOLOGY (2007)
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
C. P. Lim et al.
ONCOGENE (2006)
Share Paper
